Definitive Contract 75A50119C00078

Award Date 9/30/19
Potential Completion Date 5/29/26
Potential Value $7.2M
Ultimate Awardee
Danaher Corporation
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Miami, FL 33196, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Beckman Coulter Inc. was awarded a firm fixed price contract valued at $694,000 by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to develop the Monocyte Distribution Width (MDW) test for rapid detection of Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19 in pediatric patients. This award was made under Special Instructions 019 to the department's Easy Broad Agency Announcement BAA-20-100-SOL-0002,...
This is a $65,183,092 cost-sharing contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Beckman Coulter, Inc. to develop and commercialize a rapid antimicrobial susceptibility testing system that can deliver results within 4-6 hours. The contract has a performance period ending on May 20, 2028. Beckman Coulter, a subsidiary of Danaher Corporation, has previously been awarded federal contracts to provide clinical laboratory technologies, supplies,...
This federal contract award, valued at $3,250.60, was issued by a U.S. government agency to the prime contractor Beckman Coulter, Inc. through its U.S. Customer Operations Division. The contract is for urgent preventative maintenance and does not have a set-aside designation. Beckman Coulter, Inc. is a subsidiary of Danaher Corporation and is a global manufacturer of biomedical testing equipment, reagents, and related products and services. The company has extensive experience supporting...
This is a $894,490.80 firm fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Beckman Coulter, Inc. The contract is for ARRA-funded software and equipment to support the NIAID's biomedical research and testing initiatives, including a Biomek system and XP controller. Beckman Coulter, a subsidiary of Danaher Corporation, is a manufacturer and provider of specialized laboratory...
This $23,088.91 firm fixed price purchase order was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Beckman Coulter Inc., a subsidiary of Danaher Corporation. The service agreement has a completion date of September 3, 2023 and does not utilize a set-aside designation. Beckman Coulter is a manufacturer of biomedical testing equipment and consumables that frequently fulfills federal contracts across agencies such as the National...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Beckman Coulter, Inc., a subsidiary of Danaher Corporation. The contract, valued at $5,256.00, is a firm fixed-price purchase order for unspecified products or services related to the AMBIS #1710473 requirement. The contract does not have a set-aside designation, indicating Beckman Coulter's capabilities allow it to compete as a prime...
The U.S. Department of Health and Human Services (HHS) awarded a firm-fixed-price purchase order contract, valued at $11,346.56, to Beckman Coulter, Inc. for the maintenance of a Beckman Biomek system. The contract has no set-aside designation. Beckman Coulter, a subsidiary of Danaher Corporation, is a well-established manufacturer of laboratory instruments, reagents, and related products. The company has extensive experience providing equipment, software, and maintenance services to support...
This is a firm fixed-price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency under the Department of Health and Human Services (HHS). The contract, valued at $7,807.98, was awarded on September 11, 2017 to Beckman Coulter, Inc., a subsidiary of Danaher Corporation, for the provision of laboratory instruments, reagents, software, maintenance, calibration, testing services, and related equipment and consumables. The...
This federal contract award, HHSN272201400667P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Beckman Coulter, Inc., a subsidiary of Danaher Corporation. The $3,161.20 firm fixed-price purchase order is for the procurement of specific reagents, including NKG2A PE, CD28 ECD, and CD27 CY5 PE, to support biomedical research and testing initiatives. The contract does not have a set-aside designation,...
This is a federal contract award to Beckman Coulter, Inc., a subsidiary of Danaher Corporation, by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The contract, valued at $7,232.00, is for the delivery of miscellaneous items. It is a Delivery Order with a fixed price level of effort pricing type, with an ultimate completion date of April 30, 2011. The contract is not set aside for any specific business type. Beckman Coulter,...

This is a $7,226,322.00 definitive contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Beckman Coulter Inc., a subsidiary of Danaher Corporation. The contract is for the provision of Beckman Coulter's Monocyte Distribution Width (MDW) and predictive analytic algorithms for sepsis detection. This contract was not set aside. The original federal contract opportunity was a Broad Agency Announcement from BARDA seeking proposals for the advanced research and development of medical countermeasures against chemical, biological, radiological, nuclear and pandemic influenza threats, including diagnostics. This contract serves to advance the development of Beckman Coulter's diagnostic algorithms towards FDA approval or licensure.

Generated 5/21/24, 10:59 AM